Recombinant Anti-Mouse Ly6G Antibody: Core Reagents to Characterize Reparative Atypical Macrophages in Multiple Tissue Injury Models
Unresolved Heterogeneity of Myeloid Populations in Post-Injury Lung Microenvironments
Acute respiratory damage triggered by influenza A virus or coronavirus strains induces severe alveolar destruction and pathological inflammation, serving as standardized preclinical models for acute respiratory distress syndrome mechanism research. Traditional immunology frameworks split lung myeloid cells into fixed protective resident macrophages and pathogenic recruited monocytes, ignoring the high functional plasticity of monocyte-derived populations shaped by injury timing and local microenvironment cues. Single-cell RNA sequencing and spatial transcriptomics breakthroughs uncovered a previously unrecognized Ly6G-expressing macrophage subset concentrated at perilesional regenerative zones, which cannot be distinguished from Ly6G-positive neutrophils via conventional detection reagents. Reliable anti-Ly6G antibody tools become mandatory to separate this reparative myeloid subpopulation and dissect its unique tissue repair regulatory programs.
Distinct Spatiotemporal and Transcriptional Traits of Ly6G+ Atypical Macrophages
Ly6G+ atypical macrophages peak at day 10 post viral infection within murine pulmonary parenchyma, with negligible abundance detected in peripheral blood circulation. Morphological profiling confirms canonical macrophage signatures including indented kidney-shaped nuclei and abundant cytoplasmic vacuoles, distinct from segmented neutrophil nuclear structures. Surface antigen panels record high CD64, CXCR4, MHC-II and CD101 expression paired with minimal CD17 levels to eliminate granulocyte cross-contamination during cell sorting. Transcriptomic datasets show consistent upregulation of Arg1 and Spp1 transcripts linked to extracellular matrix remodeling and epithelial proliferation, creating a unique transcriptional signature separate from pro-inflammatory monocyte-macrophage subgroups and mature neutrophils.
Differentiation Origin and CCR2-Dependent Developmental Cascade of Ly6G+ Macrophages
EdU and Ki67 proliferation labeling experiments rule out local in situ self-renewal as the generation source of Ly6G+ macrophages within injured lung tissue. Bone marrow chimera murine models verify granulocyte-monocyte progenitors as upstream precursor pools for this reparative myeloid subset. The complete differentiation trajectory initiates from Ly6Chi classical circulating monocytes, transitioning through inflammatory monocyte intermediate states before terminal Ly6G+ macrophage reprogramming driven by lung-derived soluble signals. Competitive bone reconstitution assays with CCR2-deficient hematopoietic cells record drastically reduced Ly6G+ macrophage generation efficiency, confirming CCR2 chemokine signaling as an indispensable regulatory axis governing this differentiation route.
Spatial Co-Localization with Regenerative Alveolar Type 2 Epithelial Cells
Spatial transcriptomics and multiplex immunofluorescence capture non-uniform distribution patterns of Ly6G+ macrophages restricted to perilesional alveolar repair zones surrounding necrotic tissue lesions. PCA clustering separates transcriptomic profiles of peri-injury microdomains from uninjured lung tissue, featuring enriched gene sets controlling cytoskeletal remodeling and epithelial migration. Quantitative co-localization analysis establishes positive linear correlation between Ly6G+ macrophage density and primed alveolar type 2 progenitor cells plus dedifferentiated alveolar precursor populations. Confocal microscopic imaging visualizes direct cell-to-cell contact between Ly6G+ macrophages and regenerative AT2 cells, supporting paracrine signal exchange that accelerates alveolar structural reconstruction post tissue damage.
Cross-Model and Cross-Species Conservation of Ly6G+ Reparative Macrophages
Ly6G+ macrophage populations are not limited to viral pulmonary injury systems and can be consistently detected across chemically induced tissue damage preclinical models. Bleomycin-triggered lung fibrosis and acetaminophen-mediated hepatic injury murine cohorts both display elevated Ly6G+ myeloid cells matching the Arg1 and CXCR4 high-expression signature at tissue damage peak timepoints. Human bronchoalveolar lavage single-cell sequencing datasets identify a monocyte-derived macrophage subpopulation with conserved MAF/MAFB transcriptional signatures analogous to mouse Ly6G+ macrophages. This cross-species conservation indicates the Ly6G+ myeloid subset represents an evolutionarily universal tissue injury response module for reparative immune signaling research pipelines.
Multi-Platform Research Applications of Anti-Mouse Ly6G Recombinant Antibody
High-specificity anti-Ly6G reagents form the foundational detection toolkit for multi-layer myeloid cell mechanistic dissection workflows. Multi-color flow cytometry panels combining Ly6G with CD64 and CD11b markers enable unambiguous sorting of Ly6G+ macrophages away from neutrophil and standard monocyte populations for downstream transcriptomic profiling. FFPE and frozen tissue immunofluorescence utilizes Ly6G staining to map spatial subset distribution relative to pro-SPC-labeled AT2 regenerative epithelial cells across heterogeneous lesion microdomains. Western blot analysis quantifies total Ly6G protein abundance across injured versus uninjured tissue homogenates to benchmark myeloid subset infiltration magnitudes in comparative model cohorts.
Performance Advantages of ANT BIO PTE. LTD. S0B6402 Ly6G Recombinant Rabbit mAb
ANT BIO PTE. LTD. S0B6402 Ly6G Recombinant Rabbit mAb (Clone S-2495-6) is developed via proprietary recombinant rabbit monoclonal expression technology for murine myeloid cell profiling. Rigorous knockout cell line negative control testing eliminates off-target cross-reactivity against monocyte-macrophage surface antigens, ensuring exclusive Ly6G epitope recognition. Standardized Protein A purification delivers consistent lot-to-lot binding affinity to avoid signal deviation during long-term serial tissue microarray screening campaigns. Validated working dilutions are defined for WB (1:1000), IHC-P (1:1000) and immunofluorescence (1:100) to streamline multi-assay experimental design. Liquid storage formulation in PBS with glycerol stabilizes epitope binding activity for 12 months under -20°C preservation conditions.
Broad Basic Research Experimental Systems Supported by S0B6402 Ly6G Antibody
This Ly6G recombinant antibody fits diversified preclinical injury and immunology screening pipelines across multiple organ model systems. Viral and chemical lung damage murine cohorts utilize the reagent to quantify reparative macrophage infiltration gradients and stratify tissue repair phenotypes. Hepatic acetaminophen injury assays apply Ly6G staining to characterize myeloid population shifts during liver parenchymal regeneration. Tumor microenvironment profiling workflows pair Ly6G markers with immune checkpoint antibodies to map tumor-associated neutrophil and reparative macrophage spatial distribution. Autoimmune inflammation and organ ischemia-reperfusion models leverage the antibody to dissect dual pro-damage and pro-repair myeloid signaling cascades.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
